Lonza Finance International NV, founded in 2016 and based in Switzerland, serves as the financing arm of Lonza Group AG, a leading global supplier to the pharmaceutical, biotechnology, and specialty ingredients markets. The company primarily focuses on providing financial solutions and services that facilitate the strategic growth and operations of its parent company and its subsidiaries.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| LONNVX 1.63% 2027-04-21 EURLonza Finance International NV | Belgium | 2027-04-21 | 1.625 | 2.34 |
| LONNVX 3.50% 2034-09-04 EURLonza Finance International NV | Belgium | 2034-09-04 | 3.500 | 3.59 |
| LONNVX 3.88% 2033-05-25 EURLonza Finance International NV | Belgium | 2033-05-25 | 3.875 | 3.41 |
| LONNVX 3.88% 2036-04-24 EURLonza Finance International NV | Belgium | 2036-04-24 | 3.875 | 3.74 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Lonza Finance International NV has actively engaged in bond issuances to raise capital for corporate purposes. Notably, the company issued its first bonds in 2017, with significant offerings in recent years to support expansion projects. Current yields on their bonds are competitive within the industry, reflecting strong investor interest and the company's solid credit profile. In 2022, Lonza Finance International NV enhanced its bond features by introducing green bonds, signaling its commitment to sustainability and attracting a broader investor base.